2021
DOI: 10.2147/copd.s319220
|View full text |Cite
|
Sign up to set email alerts
|

Bronchodilator Response in Patients with COPD, Asthma-COPD-Overlap (ACO) and Asthma, Evaluated by Plethysmographic and Spirometric z-Score Target Parameters

Abstract: Background Airflow reversibility criteria in COPD are still debated – especially in situations of co-existing COPD and asthma. Bronchodilator response (BDR) is usually assessed by spirometric parameters. Changes assessed by plethysmographic parameters such as the effective, specific airway conductance (sG eff ), and changes in end-expiratory resting level at functional residual capacity (FRC pleth ) are rarely appreciated. We aimed to assess BD… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
13
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 7 publications
(13 citation statements)
references
References 57 publications
0
13
0
Order By: Relevance
“…We have recently demonstrated that the discriminating power of BDR distinguishing asthma from ACO and COPD is significantly better achieved by sG eff than FEV 1 . 16 Moreover, sWOB also improved in asthma by 76.2%, in ACO by 47.8%, and in COPD by 46.9%, compared to FEV 1 (asthma: 21.8%; ACO: 18.6%; COPD: 4.2%). 16 BDR assessed by several advanced lung function parameters was recently also studied by Jarenbäck et al, 99 suggesting that in addition to flow-response, volume-response should also be evaluated.…”
Section: Discussionmentioning
confidence: 79%
See 4 more Smart Citations
“…We have recently demonstrated that the discriminating power of BDR distinguishing asthma from ACO and COPD is significantly better achieved by sG eff than FEV 1 . 16 Moreover, sWOB also improved in asthma by 76.2%, in ACO by 47.8%, and in COPD by 46.9%, compared to FEV 1 (asthma: 21.8%; ACO: 18.6%; COPD: 4.2%). 16 BDR assessed by several advanced lung function parameters was recently also studied by Jarenbäck et al, 99 suggesting that in addition to flow-response, volume-response should also be evaluated.…”
Section: Discussionmentioning
confidence: 79%
“… 16 Moreover, sWOB also improved in asthma by 76.2%, in ACO by 47.8%, and in COPD by 46.9%, compared to FEV 1 (asthma: 21.8%; ACO: 18.6%; COPD: 4.2%). 16 BDR assessed by several advanced lung function parameters was recently also studied by Jarenbäck et al, 99 suggesting that in addition to flow-response, volume-response should also be evaluated. The overall clinical aim in COPD is to improve function in the small peripheral airways by improving flow (flow responders), as well as decreasing air trapping and pulmonary hyperinflation (volume responders).…”
Section: Discussionmentioning
confidence: 79%
See 3 more Smart Citations